KR930007451A - 우리딘을 유효성분으로 함유하는 관절염 치료제 - Google Patents

우리딘을 유효성분으로 함유하는 관절염 치료제 Download PDF

Info

Publication number
KR930007451A
KR930007451A KR1019910019146A KR910019146A KR930007451A KR 930007451 A KR930007451 A KR 930007451A KR 1019910019146 A KR1019910019146 A KR 1019910019146A KR 910019146 A KR910019146 A KR 910019146A KR 930007451 A KR930007451 A KR 930007451A
Authority
KR
South Korea
Prior art keywords
active ingredient
treatment containing
arthritis treatment
containing uridine
uridine
Prior art date
Application number
KR1019910019146A
Other languages
English (en)
Other versions
KR940008033B1 (ko
Inventor
정홍근
Original Assignee
허영섭
주식회사 녹십자
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 허영섭, 주식회사 녹십자 filed Critical 허영섭
Priority to KR1019910019146A priority Critical patent/KR940008033B1/ko
Publication of KR930007451A publication Critical patent/KR930007451A/ko
Application granted granted Critical
Publication of KR940008033B1 publication Critical patent/KR940008033B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 우리딘을 유효성분으로 하는 관절염 치료제에 관한 것이다.

Description

우라딘을 유효성분으로 함유하는 관절염 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 우리딘을 유효성분으로 함유하는 관절염 치료제.
  2. 제1항에 있어서, 우리딘의 유효량이 0.01~100㎎임을 특징으로 하는 관절염 치료제.
  3. 제1항에 있어서, 정제의 형태임을 특징으로 하는 관절염 치료제.
  4. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910019146A 1991-10-30 1991-10-30 우리딘을 유효성분으로 함유하는 콜라겐 관절염 치료제 KR940008033B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910019146A KR940008033B1 (ko) 1991-10-30 1991-10-30 우리딘을 유효성분으로 함유하는 콜라겐 관절염 치료제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910019146A KR940008033B1 (ko) 1991-10-30 1991-10-30 우리딘을 유효성분으로 함유하는 콜라겐 관절염 치료제

Publications (2)

Publication Number Publication Date
KR930007451A true KR930007451A (ko) 1993-05-20
KR940008033B1 KR940008033B1 (ko) 1994-09-01

Family

ID=19321976

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910019146A KR940008033B1 (ko) 1991-10-30 1991-10-30 우리딘을 유효성분으로 함유하는 콜라겐 관절염 치료제

Country Status (1)

Country Link
KR (1) KR940008033B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100977475B1 (ko) * 2004-05-21 2010-08-23 주식회사 머젠스 히아루론산, 글리코사미노글리칸 및/또는 콜라겐의생합성을 촉진하는 우리딘 및 우리딘 유도체

Also Published As

Publication number Publication date
KR940008033B1 (ko) 1994-09-01

Similar Documents

Publication Publication Date Title
KR910000104A (ko) 투명 조성물
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
KR890015742A (ko) 이병치료용 국소 제제
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
KR940008689A (ko) 항네프로제증후군제
KR910000114A (ko) 멜라닌 생성 억제 외용제
KR890011588A (ko) 간 섬유증 억제제
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제
KR890009395A (ko) 흡입제
KR910000115A (ko) 멜라닌 생성 억제 외용제
KR950016575A (ko) 죽염(竹鹽)-마늘환(丸)
KR940701257A (ko) 류우머티 치료약
KR930019216A (ko) 종양 치료제
KR910000106A (ko) 발모촉진제
EA199800573A1 (ru) Таблетки с высоким содержанием фамцикловира
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR880000094A (ko) 위염치료제
KR970032818A (ko) 여드름에 효과가 있는 천연 향료를 함유하는 피부용 조성물
KR940011006A (ko) 황금추출물을 유효성분으로 하는 치주질환예방 및 치료제 조성물
KR950016756A (ko) 피로회복제 조성물
KR930003909A (ko) 진해 거담제
KR900012622A (ko) 피부질환치료 조성물
KR880002520A (ko) 망막증의 치료방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050902

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee